PUS1 knock-down has been shown to inhibit hepatocellular carcinoma (HCC) cell proliferation and tumorigenesis, whereas PUS1 overexpression promotes HCC growth both in vitro and in vivo [18]. Here, PUS1 is linked to hepatocellular carcinoma.